Bicara Therapeutics Inc.

SEC 4 · Filed

0001628280-26-016874Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Mar 9, 2026

Exercise or conversion by Mazumdar Claire

Security
Stock Option (Right to Buy)
Code
M
Shares
36,766
Price per share
0.00
Structured facts
{
  "code": "M",
  "date": "2026-03-09",
  "direction": "D",
  "exercise_price": "3.7898",
  "expiration": "2033-08-08",
  "footnotes": {
    "F1": "This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.",
    "F3": "The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person\u0027s continued service on each such vesting date."
  },
  "owners": [
    {
      "cik": "0002034671",
      "name": "Mazumdar Claire",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "191107",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Stock Option (Right to Buy)",
  "shares": "36766",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "36766"
}
Insider transactionsEvent date Mar 9, 2026

Sale by Mazumdar Claire

Security
Common Stock
Code
S
Shares
36,766
Price per share
19.17Reported 19.166
Structured facts
{
  "code": "S",
  "date": "2026-03-09",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.",
    "F2": "The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.73 to $19.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."
  },
  "owners": [
    {
      "cik": "0002034671",
      "name": "Mazumdar Claire",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "339392",
  "price": "19.166",
  "row": 2,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "36766",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Mar 9, 2026

Exercise or conversion by Mazumdar Claire

Security
Common Stock
Code
M
Shares
36,766
Price per share
3.79Reported 3.7898
Structured facts
{
  "code": "M",
  "date": "2026-03-09",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025."
  },
  "owners": [
    {
      "cik": "0002034671",
      "name": "Mazumdar Claire",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "376158",
  "price": "3.7898",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "36766",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}